$FOLD Company News La-Z-Boy shares rally after
Post# of 44841
Posted On: 01/20/2015 9:32:22 AM
$FOLD Company News
La-Z-Boy shares rally after earnings beat targets 4:41 p.m. Nov. 18, 2014 - Sue Chang
Urban Outfitters slides after earnings miss expectations 4:43 p.m. Nov. 17, 2014 - Sue Chang
Apple sets intraday record; PetSmart considers sale 12:56 p.m. Aug. 20, 2014 - Ben Eisen
Amicus Therapeutics shares up 25.6% in premarket trade 7:05 a.m. Aug. 20, 2014 - Ciara Linnane
Amicus Therapeutic’s Fabry treatment meets goals in late-stage trial 7:04 a.m. Aug. 20, 2014 - Michael Calia
U.S. stocks rise as risk appetite returns 4:19 p.m. April 29, 2014 - Anora Mahmudova
Twitter rallies ahead of earnings; 3D Systems retreats 2:49 p.m. April 29, 2014 - Sue Chang
U.S. stock futures climb; House prices flat in February 8:19 a.m. April 29, 2014 - Barbara Kollmeyer
Amicus rallies 52% premarket after positive trial results 6:25 a.m. April 29, 2014 - Sara Sjolin
Amicus rallies 52% premarket after positive trial results 6:08 a.m. April 29, 2014 - Sara Sjolin
Amicus stock down after it delays seeking Fabry OK 9:44 a.m. June 17, 2013 - MarketWatch.com
Friday’s biggest gaining and declining stocks 9:45 a.m. Jan. 4, 2013 - Greg Morcroft
Amicus Therapeutics up 11% in premarket 7:52 a.m. Jan. 4, 2013 - Steve Gelsi
Thursday’s movers: Apple ends in red on price cut 5:03 p.m. Dec. 20, 2012 - Sue Chang
Amicus down 45% in premarket 8:44 a.m. Dec. 20, 2012 - Steve Gelsi
Amicus falls 47% in premarket trades 7:52 a.m. Dec. 20, 2012 - Steve Gelsi
Bed Bath shares hurt, Jabil climbs after hours 6:31 p.m. Dec. 19, 2012 - Carla Mozee
Amicus, GlaxoSmithKline say treatment misses goal 5:22 p.m. Dec. 19, 2012 - MarketWatch.com
Amicus Therapeutics shares tumble 49% after hours 4:45 p.m. Dec. 19, 2012 - Carla Mozee
U.S. Hot stocks to watch 6:28 a.m. July 18, 2012 - MarketWatch.com
Amicus Therapeutics (FOLD) Weak On High Volume 10:03 a.m. Jan. 9, 2015 - TheStreet.com
Biotech Investors Guide and Preview to the J.P. Morgan Healthcare Conference Part 1 1:09 p.m. Jan. 8, 2015 - TheStreet.com
Migalstat HCL has positive impact on cardiac endpoint in Fabry study 11:31 a.m. Jan. 8, 2015 - Seeking Alpha
Jim Cramer's 'Mad Money' Recap: Knowing Where to Look for Bargains 8:25 p.m. Jan. 6, 2015 - TheStreet.com
Use Options For A Chance To Buy FOLD At A 33% Discount 11:47 a.m. Dec. 31, 2014 - TheStreet.com
One Dad’s 14-Year Quest for Children’s Cure 7:25 p.m. Dec. 26, 2014 - The Wall Street Journal Interactive Edition
Amicus: Multiple Catalysts For Promising Fabry Treatment 12:01 p.m. Dec. 24, 2014 - Seeking Alpha
Trade-Ideas: Amicus Therapeutics (FOLD) Is Today's "Perilous Reversal" Stock 10:02 a.m. Dec. 23, 2014 - TheStreet.com
NPS Pharmaceuticals Spikes 19% Amid Shire Bid Report 10:15 a.m. Dec. 17, 2014 - benzinga.com
Nasdaq makes annual changes to Biotechnology Index 12:36 p.m. Dec. 15, 2014 - Seeking Alpha
Will Amicus Therapeutics (FOLD) Continue to Surge Higher? - Tale of the Tape 9:41 a.m. Dec. 2, 2014 - Zacks.com
Amicus Therapeutics (FOLD) Weak On High Volume 10:00 a.m. Dec. 1, 2014 - TheStreet.com
InsiderInsights.com Daily Round Up 11/25/14: AAPL, FCF, AVID, SC 1:20 a.m. Nov. 26, 2014 - Seeking Alpha
Warren Buffett Pick CBI Tumbles On Rating Downgrade 1:00 p.m. Nov. 24, 2014 - TheStreet.com
BioMarin Buying Prosensa, Backing Up Troubled Drug 9:22 a.m. Nov. 24, 2014 - Investors Business Daily
InsiderInsights.com Daily Round Up 11/19/14: CJES, MGPI, PSX, STAA 2:58 a.m. Nov. 20, 2014 - Seeking Alpha
Amicus prices stock offering 7:13 a.m. Nov. 19, 2014 - Seeking Alpha
Amicus' Migalastat Should Have Smooth Sailing To FDA And European Approval For Fabry Disease 9:47 a.m. Nov. 18, 2014 - Seeking Alpha
Amicus Therapeutics, Inc. (FOLD) in Focus: Stock Soars 17.8% - Tale of the Tape 9:21 a.m. Nov. 18, 2014 - Zacks.com
Market News: Amicus Therapeutics, Urban Outfitters, Ford 5:08 p.m. Nov. 17, 2014 - TheStreet.com
Amicus Therapeutics Announces Positive Phase 3 Data on Cardiac Endpoints From Fabry Monotherapy Study 011 and Long Term Extension Study 7:31 a.m. Jan. 8, 2015 - GlobeNewswire
Amicus Therapeutics to Present Program Updates at 33rd Annual J.P. Morgan Healthcare Conference 7:30 a.m. Dec. 22, 2014 - GlobeNewswire
Amicus Therapeutics Added to NASDAQ Biotechnology Index (NBI) 7:30 a.m. Dec. 22, 2014 - GlobeNewswire
Annual Changes to the NASDAQ Biotechnology Index 7:10 a.m. Dec. 15, 2014 - GlobeNewswire
Amicus Therapeutics to Submit European Marketing Application for Migalastat Monotherapy for Fabry Disease 7:31 a.m. Dec. 11, 2014 - GlobeNewswire
Amicus Therapeutics to Present at Oppenheimer Healthcare Conference 4:01 p.m. Dec. 4, 2014 - GlobeNewswire
Biotech Stocks Technical Coverage - OPKO Health, IsoRay, Nanosphere, Amicus Therapeutics, and Isis Pharma 8:50 a.m. Dec. 4, 2014 - PR Newswire - PRF
Amicus Therapeutics Announces Closing of Underwritten Offering of Common Stock and Full Exercise of Over-Allotment Option 4:00 p.m. Nov. 24, 2014 - GlobeNewswire
Amicus Therapeutics Prices Underwritten Offering of Common Stock 7:16 p.m. Nov. 18, 2014 - GlobeNewswire
Amicus Therapeutics Announces Public Offering of Common Stock 4:01 p.m. Nov. 17, 2014 - GlobeNewswire
Amicus Therapeutics Announces Positive Phase 3 Data on Cardiac and Composite Endpoints from Fabry Monotherapy Study 012 at American Society of Nephrology 10:01 a.m. Nov. 15, 2014 - GlobeNewswire
Amicus Therapeutics Announces Third Quarter 2014 Financial Results and Corporate Updates 4:01 p.m. Nov. 6, 2014 - GlobeNewswire
Market Momentum on Biotech Stocks - Amicus Therapeutics, Progenics Pharma, Threshold Pharma, Idera Pharma, and Merrimack Pharma 7:45 a.m. Oct. 22, 2014 - PR Newswire - PRF
Amicus Therapeutics Announces Additional Positive Phase 3 Data From Fabry Monotherapy Study 011 6:00 p.m. Oct. 19, 2014 - GlobeNewswire
Amicus Therapeutics to Present at Leerink Partners Rare Disease Roundtable 8:30 a.m. Sept. 30, 2014 - GlobeNewswire
Technical Coverage on Biotech Stocks - Exelixis, Arena Pharma, Novavax, Dendreon, and Amicus Therapeutics 7:40 a.m. Sept. 12, 2014 - PR Newswire - PRF
Clinical Trial Results, Change of Corporate Name, New Products, and Completion of Acquisition - Research Reports on GSK, Amicus, WellPoint, IDEXX and Endo 7:40 a.m. Aug. 25, 2014 - PR Newswire - PRF
Amicus Therapeutics Announces Positive Phase 3 Data From Fabry Monotherapy Study 012 5:00 a.m. Aug. 20, 2014 - GlobeNewswire
Pre-Market Review on Biotech Equities -- Exelixis, Novavax, Achillion Pharma, XOMA, and Amicus Therapeutics 7:50 a.m. Aug. 13, 2014 - PR Newswire - PRF
Amicus Therapeutics Announces Second Quarter 2014 Financial Results and Corporate Updates 3:01 p.m. Aug. 7, 2014 - GlobeNewswire
La-Z-Boy shares rally after earnings beat targets 4:41 p.m. Nov. 18, 2014 - Sue Chang
Urban Outfitters slides after earnings miss expectations 4:43 p.m. Nov. 17, 2014 - Sue Chang
Apple sets intraday record; PetSmart considers sale 12:56 p.m. Aug. 20, 2014 - Ben Eisen
Amicus Therapeutics shares up 25.6% in premarket trade 7:05 a.m. Aug. 20, 2014 - Ciara Linnane
Amicus Therapeutic’s Fabry treatment meets goals in late-stage trial 7:04 a.m. Aug. 20, 2014 - Michael Calia
U.S. stocks rise as risk appetite returns 4:19 p.m. April 29, 2014 - Anora Mahmudova
Twitter rallies ahead of earnings; 3D Systems retreats 2:49 p.m. April 29, 2014 - Sue Chang
U.S. stock futures climb; House prices flat in February 8:19 a.m. April 29, 2014 - Barbara Kollmeyer
Amicus rallies 52% premarket after positive trial results 6:25 a.m. April 29, 2014 - Sara Sjolin
Amicus rallies 52% premarket after positive trial results 6:08 a.m. April 29, 2014 - Sara Sjolin
Amicus stock down after it delays seeking Fabry OK 9:44 a.m. June 17, 2013 - MarketWatch.com
Friday’s biggest gaining and declining stocks 9:45 a.m. Jan. 4, 2013 - Greg Morcroft
Amicus Therapeutics up 11% in premarket 7:52 a.m. Jan. 4, 2013 - Steve Gelsi
Thursday’s movers: Apple ends in red on price cut 5:03 p.m. Dec. 20, 2012 - Sue Chang
Amicus down 45% in premarket 8:44 a.m. Dec. 20, 2012 - Steve Gelsi
Amicus falls 47% in premarket trades 7:52 a.m. Dec. 20, 2012 - Steve Gelsi
Bed Bath shares hurt, Jabil climbs after hours 6:31 p.m. Dec. 19, 2012 - Carla Mozee
Amicus, GlaxoSmithKline say treatment misses goal 5:22 p.m. Dec. 19, 2012 - MarketWatch.com
Amicus Therapeutics shares tumble 49% after hours 4:45 p.m. Dec. 19, 2012 - Carla Mozee
U.S. Hot stocks to watch 6:28 a.m. July 18, 2012 - MarketWatch.com
Amicus Therapeutics (FOLD) Weak On High Volume 10:03 a.m. Jan. 9, 2015 - TheStreet.com
Biotech Investors Guide and Preview to the J.P. Morgan Healthcare Conference Part 1 1:09 p.m. Jan. 8, 2015 - TheStreet.com
Migalstat HCL has positive impact on cardiac endpoint in Fabry study 11:31 a.m. Jan. 8, 2015 - Seeking Alpha
Jim Cramer's 'Mad Money' Recap: Knowing Where to Look for Bargains 8:25 p.m. Jan. 6, 2015 - TheStreet.com
Use Options For A Chance To Buy FOLD At A 33% Discount 11:47 a.m. Dec. 31, 2014 - TheStreet.com
One Dad’s 14-Year Quest for Children’s Cure 7:25 p.m. Dec. 26, 2014 - The Wall Street Journal Interactive Edition
Amicus: Multiple Catalysts For Promising Fabry Treatment 12:01 p.m. Dec. 24, 2014 - Seeking Alpha
Trade-Ideas: Amicus Therapeutics (FOLD) Is Today's "Perilous Reversal" Stock 10:02 a.m. Dec. 23, 2014 - TheStreet.com
NPS Pharmaceuticals Spikes 19% Amid Shire Bid Report 10:15 a.m. Dec. 17, 2014 - benzinga.com
Nasdaq makes annual changes to Biotechnology Index 12:36 p.m. Dec. 15, 2014 - Seeking Alpha
Will Amicus Therapeutics (FOLD) Continue to Surge Higher? - Tale of the Tape 9:41 a.m. Dec. 2, 2014 - Zacks.com
Amicus Therapeutics (FOLD) Weak On High Volume 10:00 a.m. Dec. 1, 2014 - TheStreet.com
InsiderInsights.com Daily Round Up 11/25/14: AAPL, FCF, AVID, SC 1:20 a.m. Nov. 26, 2014 - Seeking Alpha
Warren Buffett Pick CBI Tumbles On Rating Downgrade 1:00 p.m. Nov. 24, 2014 - TheStreet.com
BioMarin Buying Prosensa, Backing Up Troubled Drug 9:22 a.m. Nov. 24, 2014 - Investors Business Daily
InsiderInsights.com Daily Round Up 11/19/14: CJES, MGPI, PSX, STAA 2:58 a.m. Nov. 20, 2014 - Seeking Alpha
Amicus prices stock offering 7:13 a.m. Nov. 19, 2014 - Seeking Alpha
Amicus' Migalastat Should Have Smooth Sailing To FDA And European Approval For Fabry Disease 9:47 a.m. Nov. 18, 2014 - Seeking Alpha
Amicus Therapeutics, Inc. (FOLD) in Focus: Stock Soars 17.8% - Tale of the Tape 9:21 a.m. Nov. 18, 2014 - Zacks.com
Market News: Amicus Therapeutics, Urban Outfitters, Ford 5:08 p.m. Nov. 17, 2014 - TheStreet.com
Amicus Therapeutics Announces Positive Phase 3 Data on Cardiac Endpoints From Fabry Monotherapy Study 011 and Long Term Extension Study 7:31 a.m. Jan. 8, 2015 - GlobeNewswire
Amicus Therapeutics to Present Program Updates at 33rd Annual J.P. Morgan Healthcare Conference 7:30 a.m. Dec. 22, 2014 - GlobeNewswire
Amicus Therapeutics Added to NASDAQ Biotechnology Index (NBI) 7:30 a.m. Dec. 22, 2014 - GlobeNewswire
Annual Changes to the NASDAQ Biotechnology Index 7:10 a.m. Dec. 15, 2014 - GlobeNewswire
Amicus Therapeutics to Submit European Marketing Application for Migalastat Monotherapy for Fabry Disease 7:31 a.m. Dec. 11, 2014 - GlobeNewswire
Amicus Therapeutics to Present at Oppenheimer Healthcare Conference 4:01 p.m. Dec. 4, 2014 - GlobeNewswire
Biotech Stocks Technical Coverage - OPKO Health, IsoRay, Nanosphere, Amicus Therapeutics, and Isis Pharma 8:50 a.m. Dec. 4, 2014 - PR Newswire - PRF
Amicus Therapeutics Announces Closing of Underwritten Offering of Common Stock and Full Exercise of Over-Allotment Option 4:00 p.m. Nov. 24, 2014 - GlobeNewswire
Amicus Therapeutics Prices Underwritten Offering of Common Stock 7:16 p.m. Nov. 18, 2014 - GlobeNewswire
Amicus Therapeutics Announces Public Offering of Common Stock 4:01 p.m. Nov. 17, 2014 - GlobeNewswire
Amicus Therapeutics Announces Positive Phase 3 Data on Cardiac and Composite Endpoints from Fabry Monotherapy Study 012 at American Society of Nephrology 10:01 a.m. Nov. 15, 2014 - GlobeNewswire
Amicus Therapeutics Announces Third Quarter 2014 Financial Results and Corporate Updates 4:01 p.m. Nov. 6, 2014 - GlobeNewswire
Market Momentum on Biotech Stocks - Amicus Therapeutics, Progenics Pharma, Threshold Pharma, Idera Pharma, and Merrimack Pharma 7:45 a.m. Oct. 22, 2014 - PR Newswire - PRF
Amicus Therapeutics Announces Additional Positive Phase 3 Data From Fabry Monotherapy Study 011 6:00 p.m. Oct. 19, 2014 - GlobeNewswire
Amicus Therapeutics to Present at Leerink Partners Rare Disease Roundtable 8:30 a.m. Sept. 30, 2014 - GlobeNewswire
Technical Coverage on Biotech Stocks - Exelixis, Arena Pharma, Novavax, Dendreon, and Amicus Therapeutics 7:40 a.m. Sept. 12, 2014 - PR Newswire - PRF
Clinical Trial Results, Change of Corporate Name, New Products, and Completion of Acquisition - Research Reports on GSK, Amicus, WellPoint, IDEXX and Endo 7:40 a.m. Aug. 25, 2014 - PR Newswire - PRF
Amicus Therapeutics Announces Positive Phase 3 Data From Fabry Monotherapy Study 012 5:00 a.m. Aug. 20, 2014 - GlobeNewswire
Pre-Market Review on Biotech Equities -- Exelixis, Novavax, Achillion Pharma, XOMA, and Amicus Therapeutics 7:50 a.m. Aug. 13, 2014 - PR Newswire - PRF
Amicus Therapeutics Announces Second Quarter 2014 Financial Results and Corporate Updates 3:01 p.m. Aug. 7, 2014 - GlobeNewswire
(0)
(0)Scroll down for more posts ▼